Molecular evolution of the hemagglutinin-neuraminidase (HN) gene in human respirovirus 3.


Journal

Virus research
ISSN: 1872-7492
Titre abrégé: Virus Res
Pays: Netherlands
ID NLM: 8410979

Informations de publication

Date de publication:
02 2020
Historique:
received: 22 09 2019
revised: 08 11 2019
accepted: 25 11 2019
pubmed: 30 11 2019
medline: 10 4 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

Human respirovirus 3 (HRV3) is a major causative agent of acute respiratory infections in humans. HRV3 can manifest as a recurrent infection, although exactly how is not known. In the present study, we conducted detailed molecular evolutionary analyses of the major antigen-coding hemagglutinin-neuraminidase (HN) gene of this virus detected/isolated in various countries. We performed analyses of time-scaled evolution, similarity, selective pressure, phylodynamics, and conformational epitope prediction by mapping to HN protein models. In this way, we estimated that a common ancestor of the HN gene of HRV3 and bovine respirovirus 3 diverged around 1815 and formed many lineages in the phylogenetic tree. The evolutionary rates of the HN gene were 1.1 × 10

Identifiants

pubmed: 31783038
pii: S0168-1702(19)30683-5
doi: 10.1016/j.virusres.2019.197824
pii:
doi:

Substances chimiques

Epitopes 0
HN Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197824

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there are no conflicts of interests.

Auteurs

Jumpei Aso (J)

Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Hirokazu Kimura (H)

Department of Health Science, Gunma Paz University Graduate School of Health Science, Gunma, Japan; Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan. Electronic address: h-kimura@paz.ac.jp.

Haruyuki Ishii (H)

Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Takeshi Saraya (T)

Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Daisuke Kurai (D)

Department of General Medicine, Division of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.

Koo Nagasawa (K)

Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan.

Yuki Matsushima (Y)

Division of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.

Akihide Ryo (A)

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Hajime Takizawa (H)

Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH